Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3417976, 14 pages
http://dx.doi.org/10.1155/2016/3417976
Research Article

HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis

1Department of Infectious Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Yanjiang Road 151, Guangzhou 510120, China
2Department of Laboratory Medicine, Dongguan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Songshan Lake Avenue 22, Dongcheng District, Dongguan 523000, China

Received 15 March 2016; Accepted 6 June 2016

Academic Editor: Shinichi Aishima

Copyright © 2016 Hao Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Khan, B. R. Davidson, R. D. Goldin et al., “Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update,” Gut, vol. 61, no. 12, pp. 1657–1669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Khan, H. C. Thomas, B. R. Davidson, and S. D. Taylor-Robinson, “Cholangiocarcinoma,” The Lancet, vol. 366, no. 9493, pp. 1303–1314, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Rizvi and G. J. Gores, “Pathogenesis, diagnosis, and management of cholangiocarcinoma,” Gastroenterology, vol. 145, no. 6, pp. 1215–1229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Patel, “Worldwide trends in mortality from biliary tract malignancies,” BMC Cancer, vol. 2, article 10, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Al-Bahrani, Y. Abuetabh, N. Zeitouni, and C. Sergi, “Cholangiocarcinoma: risk factors, environmental influences and oncogenesis,” Annals of Clinical and Laboratory Science, vol. 43, no. 2, pp. 195–210, 2013. View at Google Scholar · View at Scopus
  6. Y. H. Shaib, H. B. El-Serag, J. A. Davila, R. Morgan, and K. A. McGlynn, “Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study,” Gastroenterology, vol. 128, no. 3, pp. 620–626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. “EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection,” Journal of Hepatology, vol. 57, no. 1, pp. 167–185, 2012. View at Publisher · View at Google Scholar
  8. T. Li, S.-K. Wang, J. Zhou et al., “Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC,” Liver International, vol. 36, no. 2, pp. 284–292, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Mozessohn, K. K. W. Chan, J. J. Feld, and L. K. Hicks, “Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis,” Journal of Viral Hepatitis, vol. 22, no. 10, pp. 842–849, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Matsumoto, T. Onoyama, S. Kawata et al., “Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma,” Internal Medicine, vol. 53, no. 7, pp. 651–654, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Luo, L. Yuan, Y. Wang, R. Ge, Y. Sun, and G. Wei, “Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: A Large Single-Center Cohort Study,” Journal of Gastrointestinal Surgery, vol. 18, no. 3, pp. 562–572, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R.-Q. Liu, S.-J. Shen, X.-F. Hu, J. Liu, L.-J. Chen, and X.-Y. Li, “Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors,” Cancer Cell International, vol. 13, no. 1, article 99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Yin, S.-S. Zheng, B.-H. Zhang et al., “Elevation of serum γ-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study,” European Journal of Gastroenterology and Hepatology, vol. 25, no. 12, pp. 1408–1414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Zhou, Q. Zhou, Q. Lin et al., “Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism,” International Journal of Cancer, vol. 133, no. 8, pp. 1867–1875, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. Z.-F. Wu, N. Yang, D.-Y. Li, H.-B. Zhang, and G.-S. Yang, “Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours,” Journal of Viral Hepatitis, vol. 20, no. 5, pp. 306–310, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-H. Lee, S.-Y. Hsieh, C.-J. Chang, and Y.-J. Lin, “Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers,” Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 122–127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Barusrux, C. Nanok, W. Puthisawas, C. Pairojkul, and Y. Poovorawan, “Viral hepatitis B, C infection and genotype distribution among cholangiocarcinoma patients in northeast Thailand,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 1, pp. 83–87, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Yin, B.-H. Zhang, S.-J. Qiu et al., “Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis,” Annals of Surgical Oncology, vol. 19, no. 9, pp. 2869–2876, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Qu, N. Cui, M. Qin, and X. Wu, “Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas,” Asia-Pacific Journal of Clinical Oncology, vol. 8, no. 1, pp. 83–87, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Wu, T. Wang, S. Ye et al., “Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population,” Human Pathology, vol. 43, no. 1, pp. 56–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. B.-G. Jiang, R.-L. Ge, L.-L. Sun, M. Zong, G.-T. Wei, and Y.-J. Zhang, “Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma,” Canadian Journal of Gastroenterology, vol. 25, no. 11, pp. 603–608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H.-B. Zhou, H. Wang, Y.-Q. Li et al., “Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection,” World Journal of Gastroenterology, vol. 17, no. 10, pp. 1292–1303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Park, K. H. Choi, S.-B. Choi et al., “Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea,” Yonsei Medical Journal, vol. 52, no. 5, pp. 753–760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-B. Zhou, H. Wang, D.-X. Zhou et al., “Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients,” World Journal of Gastroenterology, vol. 16, no. 7, pp. 881–885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-M. Zhou, J.-M. Yang, B. Li et al., “Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein,” World Journal of Gastroenterology, vol. 14, no. 14, pp. 2251–2254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. H.-Q. Zuo, L.-N. Yan, Y. Zeng et al., “Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma,” Hepatobiliary and Pancreatic Diseases International, vol. 6, no. 2, pp. 161–165, 2007. View at Google Scholar · View at Scopus
  28. T. Fukuhara, G. B. Sharp, T. Mizuno et al., “Liver cancer in atomic-bomb survivors: histological characteristics and relationships to radiation and hepatitis B and C viruses,” Journal of Radiation Research, vol. 42, no. 2, pp. 117–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. W.-S. Lee, K.-W. Lee, J.-S. Heo et al., “Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma,” Surgery Today, vol. 36, no. 10, pp. 892–897, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Pinyosophon and V. Wiwanitkit, “The prevalence of hepatitis B seropositivity among patients with cholangiocarcinoma,” Viral Immunology, vol. 15, no. 4, pp. 655–657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Asayama, S.-I. Aishima, K.-I. Taguchi et al., “Coexpression of neural cell adhesion molecules and bcl-2 in intrahepatic cholangiocarcinoma originated from viral hepatitis: relationship to atypical reactive bile ductule,” Pathology International, vol. 52, no. 4, pp. 300–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. B. S. Lee, E.-C. Park, S. W. Park, C. M. Nam, and J. Roh, “Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a casecontrol study in Korea,” World Journal of Gastroenterology, vol. 21, no. 2, pp. 502–510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-M. Zhou, X.-F. Zhang, L.-P. Wu, C.-J. Sui, and J.-M. Yang, “Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study,” World Journal of Gastroenterology, vol. 20, no. 35, pp. 12615–12620, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Q. Li, H. Wang, D. P. Li et al., “Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population,” Journal of Clinical Gastroenterology, vol. 48, no. 10, pp. 878–882, 2014. View at Google Scholar · View at Scopus
  35. J. S. Chang, C.-R. Tsai, and L.-T. Chen, “Medical risk factors associated with cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study,” PLoS ONE, vol. 8, no. 7, article e69981, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. N.-F. Peng, L.-Q. Li, X. Qin et al., “Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of Hepatitis B virus,” Annals of Surgical Oncology, vol. 18, no. 5, pp. 1258–1266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. W.-K. Cai, H. Sima, B.-D. Chen, and G.-S. Yang, “Risk factors for hilar cholangiocarcinoma: a case-control study in China,” World Journal of Gastroenterology, vol. 17, no. 2, pp. 249–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Srivatanakul, S. Honjo, P. Kittiwatanachot, A. Jedpiyawongse, T. Khuhaprema, and M. Miwa, “Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand,” Asian Pacific Journal of Cancer Prevention, vol. 11, no. 4, pp. 985–988, 2010. View at Google Scholar · View at Scopus
  39. H. Zhou, H. Wang, D. Zhou et al., “Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis,” European Journal of Cancer, vol. 46, no. 6, pp. 1056–1061, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. L.-Y. Tao, X.-D. He, Q. Qu et al., “Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: case-control study in China,” Liver International, vol. 30, no. 2, pp. 215–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. C. H. Lee, C. J. Chang, Y. J. Lin, C. N. Yeh, M. F. Chen, and S. Y. Hsieh, “Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma,” British Journal of Cancer, vol. 100, no. 11, pp. 1765–1770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. Y.-M. Zhou, Z.-F. Yin, J.-M. Yang et al., “Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China,” World Journal of Gastroenterology, vol. 14, no. 4, pp. 632–635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. W. Hsing, M. Zhang, A. Rashid et al., “Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China,” International Journal of Cancer, vol. 122, no. 8, pp. 1849–1853, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Y. Lee, S. S. Lee, S. W. Jung et al., “Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: A Case-Control Study,” American Journal of Gastroenterology, vol. 103, no. 7, pp. 1716–1720, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Yamamoto, S. Kubo, S. Hai et al., “Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma,” Cancer Science, vol. 95, no. 7, pp. 592–595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. G. A. Wells, B. Shea, D. O'Connell et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses, Ottawa Hospital Research Institute, Ottawa, Canada, 2012.
  47. Q. Wu, X.-D. He, L. Yu, W. Liu, and L.-Y. Tao, “The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 5, pp. 1963–1969, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Sankaranarayanan, K. Ramadas, and Y.-L. Qiao, “Managing the changing burden of cancer in Asia,” BMC Medicine, vol. 12, no. 1, article 3, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Zhou, Y. Zhao, B. Li et al., “Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis,” BMC Cancer, vol. 12, article 289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. M. R. Alison, “Liver stem cells: implications for hepatocarcinogenesis,” Stem Cell Reviews, vol. 1, no. 3, pp. 253–260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. X.-F. Liu, S.-Q. Zou, and F.-Z. Qiu, “Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus,” Hepatobiliary and Pancreatic Diseases International, vol. 2, no. 2, pp. 285–289, 2003. View at Google Scholar · View at Scopus
  52. M. Tomimatsu, N. Ishiguro, M. Taniai et al., “Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular- cholangiocarcinoma) in Japan,” Cancer, vol. 72, no. 3, pp. 683–688, 1993. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Tanaka, Y. Iwasaki, K. Nouso et al., “Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 20, no. 6, pp. 850–856, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Reddy, E. May, M. Ehrinpreis, and M. Mutchnick, “Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C,” World Journal of Gastroenterology, vol. 19, no. 48, pp. 9328–9333, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Tian, J. Li, Z.-M. Ma, C. Zhao, D.-F. Wan, and Y.-M. Wen, “Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1,” Journal of Experimental and Clinical Cancer Research, vol. 28, no. 1, article 58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Sohn, Y.-H. Paik, J. M. Kim et al., “HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma,” Annals of Surgical Oncology, vol. 21, no. 7, pp. 2429–2435, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Li, J. Li, P. Li et al., “Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review,” Journal of Gastroenterology and Hepatology, vol. 27, no. 10, pp. 1561–1568, 2012. View at Publisher · View at Google Scholar · View at Scopus